STAT+: Pharmalittle: We’re reading about the U.S. launch of a Wegovy pill, a Chinese biotech incubator, and more

Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per month for self-paying patients